Searched for
AZD1222
Oxford COVID-19 vaccine trial results due this year, trial chief says"I'm optimistic that we could reach that point before the end of this year," chief trial investigator for the vaccine, Andrew Pollard said ...04 Nov, 2020, 05.08 PM IST- Oxford COVID-19 vaccine produces immune response among elderly and young, AstraZeneca saysA vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people,...26 Oct, 2020, 02.22 PM IST
- EU reviewing Pfizer-BioNTech COVID-19 vaccine in real timePfizer and BioNTech said in a joint statement the start of the review is based on data from laboratory and animal testing, as well as early...06 Oct, 2020, 06.01 PM IST
- AstraZeneca resumes vaccine trial in Japan, in talks with U.S.Several global trials of the vaccine, AZD1222, were put on hold last month after an unexplained illness in a study participant. While most ...02 Oct, 2020, 01.50 PM IST
- Will resume COVID-19 vaccine trials after DCGI nod: Serum InstitutePharma giant AstraZeneca on Saturday said that clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the...12 Sep, 2020, 10.08 PM IST
- Oxford, AstraZeneca COVID-19 vaccine trials resume days after pauseThe study had been previously stopped in July for several days after a participant who got the vaccine developed neurological symptoms; it ...12 Sep, 2020, 09.01 PM IST
- Serum Institute of India to also halt trial of the Oxford-AstraZeneca vaccine candidateAZ on Wednesday morning said that it was temporarily halting the trial of the vaccine candidate after one of the participants developed "un...10 Sep, 2020, 12.06 PM IST
- AstraZeneca's COVID-19 vaccine reaches phase 3 clinical trials in US, says TrumpAstraZeneca is one of the leaders in the race to develop COVID-19 vaccine. Other companies that have COVID-19 vaccines in phase 3 trials in...01 Sep, 2020, 11.53 AM IST
- Bangladesh’s top pharma group & Serum Institute of India join hands for Covid-19 vaccineThe investment amount will be treated as an advance and once the vaccine receives regulatory approvals, SII will include Bangladesh among t...28 Aug, 2020, 03.35 PM IST
- AstraZeneca in first COVID-19 vaccine deal with Chinese companyThe deal underscores Astra's frontrunner position in a global race to deliver an effective vaccine, given that Chinese ventures are leading...06 Aug, 2020, 05.18 PM IST
- Wockhardt surges 10% on signing Covid-19 deal with UK governmentAs per the terms of the agreement, Wockhardt has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK gov...04 Aug, 2020, 01.03 PM IST
- AstraZeneca vaccine's success in early human trials bodes well for Adar PoonawallaAdar Poonawalla's Serum Institute of India is one of Astra Zeneca's partners in the search for the vaccine and will potentially be responsi...22 Jul, 2020, 10.37 AM IST
- Serum Institute investing USD 100 million on potential COVID-19 vaccine"Our manufacturing facility is ready and we plan to start production in two months. We are spending more than USD 100 million for this faci...10 Jun, 2020, 10.58 AM IST
- COVID-19: Infections rise, so do vaccine trialsEver since the Covid-19 outbreak late last year, the world has been moving much faster with regards to working on a vaccine and a possible ...06 Jun, 2020, 07.16 AM IST
- AstraZeneca & Serum Institute of India sign licensing deal for 1 billion doses of Oxford vaccineThe British drug maker also reached a $750m agreement with Coalition for Epidemic Preparedness Innovation (CEPI) and Gavi to support the ma...04 Jun, 2020, 10.39 PM IST
- How one Indian company could be world's door to a COVID-19 vaccineSerum Institute, the world's largest manufacturer of vaccines, is working on several candidates.23 May, 2020, 02.00 PM IST
- Serum Institute, AstraZeneca in talks for vaccine SupplyAstraZeneca also received $1 billion from the US government’s Biomedical Advanced Research and Development Authority (BARDA) for the develo...22 May, 2020, 08.43 AM IST
Load More
